Skip to content

H.R. 1492 · 119th Congress (2025–2027)

To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.

This bill lengthens the amount of time for which drug products must have market approval in order for the products to qualify for negotiation under the Medicare Drug Price Negotiation Program.

The Medicare Drug Price Negotiation Program requires the Centers for Medicare & Medicaid Services to negotiate the prices of certain prescription drugs under Medicare beginning in 2026. Among other requirements, drugs must have had market approval for at least 7 years (for drug products) or 11 years (for biologics) to qualify for negotiation.

The bill modifies these provisions so as to require drug products to also have had at least 11 years of market approval in order to qualify for negotiation.

The bill's changes apply retroactively.

Referred to committee

Latest actionReferred to committee

This bill’s path

This is H.R. 1492’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced

  2. Passed House

  3. Passed Senate

  4. Sent to President

  5. Signed into law

Sponsor
Rep. Gregory F. Murphy (R-NC-3)
Cosponsors
68 cosponsors

2 original · 66 later

64 R · 4 D

  1. Rep. Donald G. Davis (D-NC-1)· Original · Feb 21, 2025
  2. Rep. Richard Hudson (R-NC-9)· Original · Feb 21, 2025
  3. Rep. Vern Buchanan (R-FL-16)· Later · Mar 24, 2025
  4. Rep. Dan Crenshaw (R-TX-2)· Later · Mar 24, 2025
  5. Rep. Neal P. Dunn (R-FL-2)· Later · Mar 24, 2025
  6. Rep. Thomas H. Kean, Jr. (R-NJ-7)· Later · Mar 24, 2025
  7. Rep. Nicole Malliotakis (R-NY-11)· Later · Mar 24, 2025
  8. Rep. Carol D. Miller (R-WV-1)· Later · Mar 24, 2025
  9. Rep. Mariannette Miller-Meeks (R-IA-1)· Later · Mar 24, 2025
  10. Rep. Tim Moore (R-NC-14)· Later · Mar 24, 2025
  11. Rep. Claudia Tenney (R-NY-24)· Later · Mar 24, 2025
  12. Rep. Beth Van Duyne (R-TX-24)· Later · Mar 24, 2025
  13. Rep. Rudy Yakym III (R-IN-2)· Later · Mar 24, 2025
  14. Rep. Nathaniel Moran (R-TX-1)· Later · Mar 25, 2025
  15. Rep. August Pfluger (R-TX-11)· Later · Mar 26, 2025
  16. Rep. James Comer (R-KY-1)· Later · Apr 1, 2025
  17. Rep. Brian K. Fitzpatrick (R-PA-1)· Later · Apr 1, 2025
  18. Rep. Andy Harris (R-MD-1)· Later · Apr 1, 2025
  19. Rep. Addison P. McDowell (R-NC-6)· Later · Apr 1, 2025
  20. Rep. Rick W. Allen (R-GA-12)· Later · Apr 8, 2025
  21. Rep. Gabe Evans (R-CO-8)· Later · Apr 8, 2025
  22. Rep. Mike Haridopolos (R-FL-8)· Later · Apr 8, 2025
  23. Rep. Bryan Steil (R-WI-1)· Later · Apr 8, 2025
  24. Rep. W. Gregory Steube (R-FL-17)· Later · Apr 8, 2025
  25. Rep. Aaron Bean (R-FL-4)· Later · Apr 17, 2025
  26. Rep. Robert P. Bresnahan, Jr. (R-PA-8)· Later · Apr 17, 2025
  27. Rep. J. French Hill (R-AR-2)· Later · Apr 17, 2025
  28. Rep. Brian Jack (R-GA-3)· Later · Apr 17, 2025
  29. Rep. Mike Kelly (R-PA-16)· Later · Apr 17, 2025
  30. Rep. Brad Knott (R-NC-13)· Later · Apr 17, 2025
  31. Rep. Richard McCormick (R-GA-7)· Later · Apr 17, 2025
  32. Rep. Mark E. Amodei (R-NV-2)· Later · Apr 24, 2025
  33. Rep. Erin Houchin (R-IN-9)· Later · Apr 24, 2025
  34. Rep. Andrew Ogles (R-TN-5)· Later · Apr 24, 2025
  35. Rep. Michael A. Rulli (R-OH-6)· Later · Apr 24, 2025
  36. Rep. Lloyd Smucker (R-PA-11)· Later · Apr 24, 2025
  37. Rep. Randy K. Weber, Sr. (R-TX-14)· Later · Apr 24, 2025
  38. Rep. Kat Cammack (R-FL-3)· Later · Apr 29, 2025
  39. Rep. Mike Flood (R-NE-1)· Later · Apr 29, 2025
  40. Rep. Robert E. Latta (R-OH-5)· Later · Apr 29, 2025
  41. Rep. Troy Balderson (R-OH-12)· Later · Apr 30, 2025
  42. Rep. Pat Harrigan (R-NC-10)· Later · May 1, 2025
  43. Rep. Mike Carey (R-OH-15)· Later · May 7, 2025
  44. Rep. Julie Fedorchak (R-ND)· Later · May 7, 2025
  45. Rep. Diana Harshbarger (R-TN-1)· Later · May 7, 2025
  46. Rep. David Rouzer (R-NC-7)· Later · May 7, 2025
  47. Rep. Jefferson Shreve (R-IN-6)· Later · May 7, 2025
  48. Rep. Russell Fry (R-SC-7)· Later · May 8, 2025
  49. Rep. Michael Baumgartner (R-WA-5)· Later · May 9, 2025
  50. Rep. Craig A. Goldman (R-TX-12)· Later · May 9, 2025
  51. Rep. Kevin Hern (R-OK-1)· Later · May 9, 2025
  52. Rep. Zachary Nunn (R-IA-3)· Later · May 19, 2025
  53. Rep. David Kustoff (R-TN-8)· Later · May 29, 2025
  54. Rep. Scott Fitzgerald (R-WI-5)· Later · Jun 6, 2025
  55. Rep. Ashley Hinson (R-IA-2)· Later · Jun 6, 2025
  56. Rep. Michelle Fischbach (R-MN-7)· Later · Jun 10, 2025
  57. Rep. Cliff Bentz (R-OR-2)· Later · Jun 26, 2025
  58. Rep. Juan Ciscomani (R-AZ-6)· Later · Jul 10, 2025
  59. Rep. Mike Kennedy (R-UT-3)· Later · Jul 29, 2025
  60. Rep. Max L. Miller (R-OH-7)· Later · Jul 29, 2025
  61. Rep. Earl L. "Buddy" Carter (R-GA-1)· Later · Sep 10, 2025
  62. Rep. Vince Fong (R-CA-20)· Later · Sep 10, 2025
  63. Rep. Bill Huizenga (R-MI-4)· Later · Oct 3, 2025
  64. Rep. John J. McGuire III (R-VA-5)· Later · Oct 8, 2025
  65. Rep. Adrian Smith (R-NE-3)· Later · Dec 16, 2025
  66. Rep. Scott H. Peters (D-CA-50)· Later · Feb 12, 2026
  67. Rep. Brendan F. Boyle (D-PA-2)· Later · Apr 27, 2026
  68. Rep. Jared Moskowitz (D-FL-23)· Later · Jun 23, 2026
Policy area
Health
Subjects
  • Health care costs and insurance
  • Medicare
  • Prescription drugs

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Introduced in House

    Document: Introduced in House

    Sources
  2. Latest

    Referred to committee

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Sources

Committees

  1. HouseEnergy and CommerceReferred Feb 21, 2025
  2. HouseWays and MeansReferred Feb 21, 2025

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in House
Titles (1)
  1. To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.

    Display title, Official title · Introduced in House